Schonfeld Strategic Advisors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-503,674
| Closed | -$2.94M | – | 2816 |
|
|
2022
Q4 | $2.94M | Buy |
503,674
+244,574
| +94% | +$1.43M | 0.02% | 670 |
|
|
2022
Q3 | $1.74M | Buy |
259,100
+199,500
| +335% | +$1.34M | 0.01% | 934 |
|
|
2022
Q2 | $251K | Buy |
+59,600
| New | +$251K | ﹤0.01% | 1688 |
|
|
2019
Q2 | – | Sell |
-62,400
| Closed | -$754K | – | 1313 |
|
|
2019
Q1 | $754K | Buy |
+62,400
| New | +$754K | 0.03% | 581 |
|
|
2017
Q2 | – | Sell |
-61,831
| Closed | -$1.06M | – | 811 |
|
|
2017
Q1 | $1.06M | Sell |
61,831
-28,169
| -31% | -$481K | 0.11% | 248 |
|
|
2016
Q4 | $926K | Buy |
+90,000
| New | +$926K | 0.12% | 242 |
|